FindTrial
Sign In

Eylea (aflibercept)

DRUG8 trials

Sponsors

Department of Ophthalmology, Kagawa university faculty of medicine, Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Jichi Medical University, Department of Ophthalmology, Jikei University School of Medicine, Asahikawa Medical University

Conditions

Age-related macular degenerationBranch retinal vein occlusionNeovascular Age-related Macular DegenerationPolypoidal Choroidal Vasculopathycentral retinal vein occlusion

Phase 3

A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)
CompletedNCT04450329
Samsung Bioepis Co., Ltd.Neovascular Age-related Macular Degeneration
Start: 2020-06-23End: 2022-03-16Updated: 2024-02-05

Phase 4

The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)
Active, not recruitingJPRN-UMIN000023200
Department of Ophthalmology, Akita UniversityBranch retinal vein occlusion
Start: 2016-10-17Target: 50Updated: 2026-06-29

Unknown Phase

Study of Eylea in patients with wet age-related macular degeneration
Active, not recruitingJPRN-UMIN000010171
Department of Ophthalmology, Kagawa university faculty of medicineAge-related macular degeneration
Start: 2013-03-06Target: 50Updated: 2026-06-29
Investigation of clinical efficacy for Aflibercept in patients with polypoidal choroidal vasculopathy (PCV)
Active, not recruitingJPRN-UMIN000011091
Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu UniversityPolypoidal Choroidal Vasculopathy
Start: 2013-07-02Target: 50Updated: 2026-06-29
Study of visual and anatomical outcomes of aflibercept in good visual acuity baseline of wet age-related macular degeneration
Active, not recruitingJPRN-UMIN000011337
Jichi Medical UniversityAge-related macular degeneration
Start: 2013-08-01Target: 50Updated: 2026-06-29
Study of intravitreal aflibercept for exudative age-related macular degeneration
Active, not recruitingJPRN-UMIN000012126
Department of Ophthalmology, Jikei University School of MedicineAge-related macular degeneration
Start: 2013-10-25Target: 30Updated: 2026-06-29
Efficacy of aflibercept for Macular edema secondary to central retinal vein occlusion (CRVO)
RecruitingJPRN-UMIN000014505
Asahikawa Medical Universitycentral retinal vein occlusion
Start: 2014-07-08Target: 30Updated: 2026-06-29
Study of visual and anatomical outcomes of second year aflibercept in good visual acuity baseline of wet age-related macular degeneration
Active, not recruitingJPRN-UMIN000016598
Department of Ophthalmology, Jichi Medical UniversityAge-related macular degeneration
Start: 2015-02-22Target: 42Updated: 2026-06-29

Related Papers

Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration
JAMA Ophthalmology2023-06-0827 citations